Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zev A Binder

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
JCO Precision Oncology|September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for GlioblastomaErica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2022
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumorsYibo Yin, Jesse L Rodriguez, Nannan Li, et al.
Scientific Reports|February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approachJun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Science Advances|October 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent GlioblastomaElizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
Oncogene|February 19, 2020
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastomaNina Struve, Zev A Binder, Lucy F Stead, et al.
Communications Medicine|March 2, 2025
The radiogenomic and spatiogenomic landscapes of glioblastoma and their relationship to oncogenic driversAnahita Fathi Kazerooni, Hamed Akbari, Xiaoju Hu, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
JCO Precision Oncology|September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for GlioblastomaErica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2022
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumorsYibo Yin, Jesse L Rodriguez, Nannan Li, et al.
Scientific Reports|February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approachJun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Science Advances|October 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent GlioblastomaElizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
Oncogene|February 19, 2020
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastomaNina Struve, Zev A Binder, Lucy F Stead, et al.
Communications Medicine|March 2, 2025
The radiogenomic and spatiogenomic landscapes of glioblastoma and their relationship to oncogenic driversAnahita Fathi Kazerooni, Hamed Akbari, Xiaoju Hu, et al.
Pageof 7